What is Travelers Compan's earnings per share (EPS)?

Travelers Compan (TRV) reported diluted earnings per share of $27.43 for fiscal year 2025. This represents a 27.8% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Travelers Compan Financials

TRV

Trailing 12 months to June 30, 2026

Revenue $49.0B +2.4% YoY

Net Income $8.3B +58.3% YoY

EPS (Diluted) $37.26 +64.8% YoY

Free Cash Flow Not reported for the trailing 12 months

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Jul 17, 2026 Currency USD FYE December

Travelers Compan (TRV) reported $49.0B in revenue over the twelve months to Jun 30, 2026, up 2.4% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI TRV FY2025 2026-08-29

Earnings recovery converted into cash while lower leverage and repurchases reshaped the company’s capital structure.

The key shift is earnings quality: net margin rose from 7.2% to 12.9%, indicating a much larger share of revenue reached the bottom line. In the latest year, operating cash flow of $10.6B exceeded net income of $6.3B, showing that reported profitability was accompanied by strong cash realization rather than relying solely on accounting earnings.

Balance-sheet capacity improved as debt-to-equity declined from 4.1x to 3.4x, reducing the liabilities burden relative to shareholders’ capital. Equity also expanded from $24.9B to $32.9B, so the leverage improvement reflected both lower relative debt and a stronger capital base.

Capital allocation became more assertive: the latest year included $3.0B of share repurchases, alongside a share count of 216.2M. That combination directs part of the cash-generation improvement to per-share ownership while leaving the balance sheet less leveraged than in earlier periods.

Financial Health Signals

Financial Health Score 46/100

Scored as: Insurers peer group

Scored against insurers for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Travelers Compan's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Loss Ratio

Premium Growth

Capital

Investment Yield

Not available for Travelers Compan, and counted as zero in the overall score.

Combined Ratio

Stability

Piotroski F-Score Partial

5/6

Travelers Compan passes 5 of 6 computable financial strength tests (3 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), all 1 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed

1.69x

For every $1 of reported earnings, Travelers Compan generates $1.69 in operating cash flow ($10.6B OCF vs $6.3B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$48.8B

YoY+5.2%

5Y CAGR+8.8%

10Y CAGR+6.2%

Travelers Compan generated $48.8B in revenue in fiscal year 2025. This represents an increase of 5.2% from the prior year.

Net Income

$6.3B

YoY+25.8%

5Y CAGR+18.4%

10Y CAGR+6.2%

Travelers Compan reported $6.3B in net income in fiscal year 2025. This represents an increase of 25.8% from the prior year.

EPS (Diluted)

$27.43

YoY+27.8%

5Y CAGR+21.1%

10Y CAGR+9.7%

Travelers Compan earned $27.43 per diluted share (EPS) in fiscal year 2025. This represents an increase of 27.8% from the prior year.

EBITDA

Not reported for fiscal year 2025.

Cash & Balance Sheet

Cash & Debt

$842.0M

YoY+20.5%

5Y CAGR+3.2%

10Y CAGR+8.3%

Travelers Compan held $842.0M in cash as of fiscal year 2025; long-term debt is not reported for that period.

Shares Outstanding

216M

YoY-4.6%

5Y CAGR-3.0%

10Y CAGR-3.1%

Travelers Compan had 216M shares outstanding in fiscal year 2025. This represents a decrease of 4.6% from the prior year.

Free Cash Flow

Not reported for fiscal year 2025.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Net Margin

12.9%

YoY+2.1pp

5Y CAGR+4.5pp

10Y CAGR+0.1pp

Travelers Compan's net profit margin was 12.9% in fiscal year 2025, showing the share of revenue converted to profit. This is up 2.1 percentage points from the prior year.

Return on Equity

19.1%

YoY+1.2pp

5Y CAGR+9.9pp

10Y CAGR+4.6pp

Travelers Compan's ROE was 19.1% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 1.2 percentage points from the prior year.

Gross Margin

Not reported for fiscal year 2025.

Operating Margin

Not reported for fiscal year 2025.

Capital Allocation

Share Buybacks

$3.0B

YoY+199.5%

5Y CAGR+36.9%

10Y CAGR-0.5%

Travelers Compan spent $3.0B on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 199.5% from the prior year.

R&D Spending

Not reported for fiscal year 2025.

Capital Expenditures

Not reported for fiscal year 2025.

TRV Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

TRV quarterly income statement

Metric	TTM	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Revenue	$49.0B	$48.8B+5.2%	$46.4B+12.2%	$41.4B+12.1%	$36.9B+5.9%	$34.8B+8.9%	$32.0B+1.3%	$31.6B+4.3%	$30.3B+4.8%	$28.9B+4.6%	$27.6B+3.0%	$26.8B-1.3%	$27.2B+3.8%	$26.2B+1.8%	$25.7B+1.2%	$25.4B
SG&A Expenses	$6.2B	$6.1B+5.2%	$5.8B+12.4%	$5.2B+7.6%	$4.8B+2.8%	$4.7B+3.7%	$4.5B+3.3%	$4.4B+1.6%	$4.3B+3.0%	$4.2B+0.4%	$4.2B+1.5%	$4.1B+3.3%	$4.0B+5.5%	$3.8B+4.1%	$3.6B+1.5%	$3.6B
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$3.6B+2.1%	$3.6B+46.1%	$2.4B+75.6%	$1.4B
Interest Expense	$456.0M	$425.0M+8.4%	$392.0M+4.3%	$376.0M+7.1%	$351.0M+3.2%	$340.0M+0.3%	$339.0M-1.5%	$344.0M-2.3%	$352.0M-4.6%	$369.0M+1.7%	$363.0M-2.7%	$373.0M+1.1%	$369.0M+2.2%	$361.0M-4.5%	$378.0M-2.1%	$386.0M
Income Tax	$2.0B	$1.5B+27.7%	$1.2B+210.8%	$380.0M-25.8%	$512.0M-35.7%	$796.0M+47.4%	$540.0M+4.7%	$516.0M+17.8%	$438.0M-35.0%	$674.0M-35.1%	$1.0B-20.1%	$1.3B-6.9%	$1.4B+9.8%	$1.3B+83.5%	$693.0M+1036.5%	-$74.0M
Net Income	$8.3B	$6.3B+25.8%	$5.0B+67.1%	$3.0B+5.2%	$2.8B-22.4%	$3.7B+35.8%	$2.7B+2.9%	$2.6B+3.9%	$2.5B+22.7%	$2.1B-31.8%	$3.0B-12.4%	$3.4B-6.9%	$3.7B+0.5%	$3.7B+48.5%	$2.5B+73.4%	$1.4B
EPS (Diluted)	$37.26	$27.43+27.8%	$21.47+67.9%	$12.79+8.7%	$11.77-18.8%	$14.49+37.7%	$10.52+6.0%	$9.92+6.9%	$9.28+26.6%	$7.33-28.7%	$10.28-5.5%	$10.88+1.7%	$10.70+9.9%	$9.74+54.6%	$6.30+87.5%	$3.36

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Revenue	$12.2B+1.9%	$11.9B-4.1%	$12.4B-0.3%	$12.5B+2.9%	$12.1B+2.6%	$11.8B-1.6%	$12.0B+0.9%	$11.9B
SG&A Expenses	$1.6B+1.6%	$1.5B-0.2%	$1.5B-1.8%	$1.6B+1.7%	$1.5B+5.9%	$1.5B-1.1%	$1.5B+1.0%	$1.5B
Interest Expense	$113.0M-2.6%	$116.0M0.0%	$116.0M+4.5%	$111.0M+12.1%	$99.0M0.0%	$99.0M+1.0%	$98.0M0.0%	$98.0M
Income Tax	$559.0M+37.0%	$408.0M-32.8%	$607.0M+33.1%	$456.0M+22.6%	$372.0M+409.6%	$73.0M-85.7%	$512.0M+70.7%	$300.0M
Net Income	$2.2B+29.0%	$1.7B-31.5%	$2.5B+32.2%	$1.9B+25.1%	$1.5B+282.0%	$395.0M-81.0%	$2.1B+65.2%	$1.3B
EPS (Diluted)	$10.26+31.9%	$7.78-29.1%	$10.98+33.3%	$8.24+26.2%	$6.53+284.1%	$1.70-81.0%	$8.96+65.3%	$5.42

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, Operating Income.

TRV Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

TRV quarterly balance sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Total Assets	$143.7B+7.9%	$133.2B+5.7%	$126.0B+8.9%	$115.7B-3.9%	$120.5B+3.2%	$116.8B+6.0%	$110.1B+5.6%	$104.2B+0.7%	$103.5B+3.2%	$100.2B+0.1%	$100.2B-2.8%	$103.1B-0.7%	$103.8B-1.1%	$104.9B+0.3%	$104.6B
Cash & Equivalents	$842.0M+20.5%	$699.0M+7.5%	$650.0M-18.6%	$799.0M+5.0%	$761.0M+5.5%	$721.0M+46.0%	$494.0M+32.4%	$373.0M+8.4%	$344.0M+12.1%	$307.0M-19.2%	$380.0M+1.6%	$374.0M+27.2%	$294.0M-10.9%	$330.0M+54.2%	$214.0M
Goodwill	$4.1B-3.9%	$4.2B+6.5%	$4.0B+0.6%	$4.0B-1.4%	$4.0B+0.8%	$4.0B+0.4%	$4.0B+0.6%	$3.9B-0.4%	$4.0B+10.4%	$3.6B+0.2%	$3.6B-1.1%	$3.6B-0.6%	$3.6B+8.0%	$3.4B0.0%	$3.4B
Total Liabilities	$110.8B+5.2%	$105.3B+4.2%	$101.1B+7.3%	$94.2B+2.8%	$91.6B+4.6%	$87.6B+4.0%	$84.2B+3.5%	$81.3B+2.0%	$79.8B+3.5%	$77.0B+0.6%	$76.6B-2.1%	$78.2B-1.0%	$79.0B-0.7%	$79.5B-0.7%	$80.1B
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$5.9B-6.4%	$6.3B+8.7%	$5.8B-8.1%	$6.3B
Total Equity	$32.9B+18.1%	$27.9B+11.8%	$24.9B+15.6%	$21.6B-25.4%	$28.9B-1.1%	$29.2B+12.6%	$25.9B+13.3%	$22.9B-3.5%	$23.7B+2.2%	$23.2B-1.6%	$23.6B-5.0%	$24.8B+0.2%	$24.8B-2.4%	$25.4B+3.8%	$24.5B
Retained Earnings	$54.9B+10.7%	$49.6B+8.9%	$45.6B+4.8%	$43.5B+4.7%	$41.6B+7.2%	$38.8B+4.9%	$37.0B+5.0%	$35.2B+5.2%	$33.5B+3.9%	$32.2B+7.5%	$29.9B+9.9%	$27.3B+12.2%	$24.3B+13.8%	$21.4B+9.1%	$19.6B

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Total Assets	$143.6B+0.9%	$142.3B-1.0%	$143.7B0.0%	$143.7B+3.5%	$138.9B+2.1%	$136.0B+2.1%	$133.2B-1.0%	$134.6B
Cash & Equivalents	$621.0M+1.0%	$615.0M-27.0%	$842.0M+15.5%	$729.0M+10.6%	$659.0M-9.0%	$724.0M+3.6%	$699.0M-9.5%	$772.0M
Goodwill	$4.1B0.0%	$4.1B-0.1%	$4.1B-4.8%	$4.3B-0.3%	$4.3B+0.9%	$4.2B+0.3%	$4.2B-0.9%	$4.3B
Total Liabilities	$110.5B+0.1%	$110.3B-0.4%	$110.8B-1.1%	$112.1B+2.5%	$109.4B+1.5%	$107.8B+2.3%	$105.3B-1.5%	$106.9B
Total Equity	$33.1B+3.5%	$32.0B-2.8%	$32.9B+4.1%	$31.6B+7.1%	$29.5B+4.7%	$28.2B+1.2%	$27.9B+0.6%	$27.7B
Retained Earnings	$58.3B+3.4%	$56.4B+2.7%	$54.9B+4.3%	$52.7B+3.2%	$51.0B+2.5%	$49.8B+0.3%	$49.6B+3.9%	$47.8B

Not reported in any period shown, so not listed: Current Assets, Inventory, Accounts Receivable, Current Liabilities, Long-Term Debt.

TRV Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

TRV quarterly cash flow statement

Metric	TTM	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Operating Cash Flow	$11.0B	$10.6B+16.9%	$9.1B+17.7%	$7.7B+19.3%	$6.5B-11.1%	$7.3B+11.6%	$6.5B+25.2%	$5.2B+18.8%	$4.4B+5.6%	$4.1B-7.2%	$4.5B+30.1%	$3.4B-7.0%	$3.7B-3.2%	$3.8B+18.1%	$3.2B+48.9%	$2.2B
Investing Cash Flow	-$5.6B	-$7.7B-5.3%	-$7.3B-6.5%	-$6.8B-83.0%	-$3.7B+28.3%	-$5.2B-6.2%	-$4.9B-68.6%	-$2.9B-24.6%	-$2.3B-5.8%	-$2.2B-27.5%	-$1.7B-644.8%	$317.0M	N/A	N/A	N/A	N/A
Financing Cash Flow	-$5.3B	-$2.7B-52.4%	-$1.7B-66.2%	-$1.1B+60.6%	-$2.7B-31.0%	-$2.0B-43.9%	-$1.4B+35.3%	-$2.2B-8.7%	-$2.0B-4.8%	-$1.9B+31.6%	-$2.8B+24.8%	-$3.7B	N/A	N/A	N/A	N/A
Dividends Paid	$989.0M	$979.0M+2.9%	$951.0M+4.7%	$908.0M+3.8%	$875.0M+0.7%	$869.0M+0.9%	$861.0M+2.0%	$844.0M+3.7%	$814.0M+3.7%	$785.0M+3.7%	$757.0M+2.4%	$739.0M+1.4%	$729.0M0.0%	$729.0M+4.1%	$700.0M+4.6%	$669.0M
Share Buybacks	$5.4B	$3.0B+199.5%	$1.0B+4.7%	$958.0M-52.1%	$2.0B-7.2%	$2.2B+245.0%	$625.0M-58.3%	$1.5B+18.1%	$1.3B-7.8%	$1.4B-42.6%	$2.4B-23.8%	$3.1B-3.8%	$3.3B+36.5%	$2.4B	N/A	N/A

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Operating Cash Flow	$1.9B-12.8%	$2.2B-18.1%	$2.7B-36.5%	$4.2B+81.1%	$2.3B+71.6%	$1.4B-34.1%	$2.1B-46.7%	$3.9B
Investing Cash Flow	-$165.0M+50.7%	-$335.0M+41.7%	-$575.0M+87.4%	-$4.6B-165.3%	-$1.7B-112.4%	-$808.0M+52.3%	-$1.7B+50.1%	-$3.4B
Financing Cash Flow	-$1.7B+16.4%	-$2.1B-14.1%	-$1.8B-554.7%	$402.0M+157.3%	-$702.0M-31.2%	-$535.0M-26.8%	-$422.0M+7.0%	-$454.0M
Dividends Paid	$263.0M+11.0%	$237.0M-2.1%	$242.0M-2.0%	$247.0M-1.2%	$250.0M+4.2%	$240.0M0.0%	$240.0M+0.8%	$238.0M
Share Buybacks	$1.3B-26.4%	$1.8B+9.2%	$1.6B+164.1%	$619.0M+23.8%	$500.0M+100.0%	$250.0M-2.3%	$256.0M+3.2%	$248.0M

Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow.

TRV Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

TRV quarterly financial ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	13.4%-0.2pp	13.6%+4.1pp	9.5%+4.0pp	5.5%
Net Margin	12.9%+2.1pp	10.8%+3.5pp	7.2%-0.5pp	7.7%-2.8pp	10.5%+2.1pp	8.4%+0.1pp	8.3%0.0pp	8.3%+1.2pp	7.1%-3.8pp	10.9%-1.9pp	12.8%-0.8pp	13.6%-0.4pp	14.0%+4.4pp	9.6%+4.0pp	5.6%
Return on Equity	19.1%+1.2pp	17.9%+5.9pp	12.0%-1.2pp	13.2%+0.5pp	12.7%+3.4pp	9.2%-0.9pp	10.1%-0.9pp	11.0%+2.4pp	8.7%-4.3pp	13.0%-1.6pp	14.6%-0.3pp	14.9%+0.1pp	14.8%+5.1pp	9.7%+3.9pp	5.8%
Return on Assets	4.4%+0.6pp	3.8%+1.4pp	2.4%-0.1pp	2.5%-0.6pp	3.0%+0.7pp	2.3%-0.1pp	2.4%0.0pp	2.4%+0.4pp	2.0%-1.0pp	3.0%-0.4pp	3.4%-0.2pp	3.6%0.0pp	3.5%+1.2pp	2.4%+1.0pp	1.4%
Debt-to-Equity	3.37-0.4x	3.78-0.3x	4.06-0.3x	4.37+1.2x	3.17+0.2x	3.00-0.2x	3.24-0.3x	3.55+0.2x	3.360.0x	3.32+0.1x	3.25+3.0x	0.240.0x	0.250.0x	0.230.0x	0.26

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Net Margin	18.2%+3.8pp	14.3%-5.7pp	20.1%+4.9pp	15.1%+2.7pp	12.4%+9.1pp	3.3%-14.0pp	17.3%+6.8pp	10.6%
Return on Equity	6.7%+1.3pp	5.3%-2.2pp	7.6%+1.6pp	6.0%+0.9pp	5.1%+3.7pp	1.4%-6.1pp	7.5%+2.9pp	4.5%
Return on Assets	1.5%+0.3pp	1.2%-0.5pp	1.7%+0.4pp	1.3%+0.2pp	1.1%+0.8pp	0.3%-1.3pp	1.6%+0.6pp	0.9%
Debt-to-Equity	3.33-0.1x	3.45+0.1x	3.37-0.2x	3.55-0.2x	3.70-0.1x	3.820.0x	3.78-0.1x	3.86

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio, FCF Margin.

Similar Companies

Allstate Corp ALL

$65.9B

Chubb Limited CB

$131.1B

The Hartford Insurance Group Inc HIG

$37.5B

Progress Corp Oh PGR

$127.1B

W.R Berkley WRB

$25.4B

Where Travelers Compan Ranks

Frequently Asked Questions

What is Travelers Compan's annual revenue?

Travelers Compan (TRV) reported $48.8B in total revenue for fiscal year 2025. This represents a 5.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Travelers Compan's revenue growing?

Travelers Compan (TRV) revenue grew by 5.2% year-over-year, from $46.4B to $48.8B in fiscal year 2025.

Is Travelers Compan profitable?

Yes, Travelers Compan (TRV) reported a net income of $6.3B in fiscal year 2025, with a net profit margin of 12.9%.

What is Travelers Compan's net profit margin?

Travelers Compan (TRV) had a net profit margin of 12.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Travelers Compan's return on equity (ROE)?

Travelers Compan (TRV) has a return on equity of 19.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Travelers Compan's operating cash flow?

Travelers Compan (TRV) generated $10.6B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Travelers Compan's total assets?

Travelers Compan (TRV) had $143.7B in total assets as of fiscal year 2025, including both current and long-term assets.

Does Travelers Compan buy back shares?

Yes, Travelers Compan (TRV) spent $3.0B on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Travelers Compan have outstanding?

Travelers Compan (TRV) had 216M shares outstanding as of fiscal year 2025.

What is Travelers Compan's debt-to-equity ratio?

Travelers Compan (TRV) had a debt-to-equity ratio of 3.37 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Travelers Compan's return on assets (ROA)?

Travelers Compan (TRV) had a return on assets of 4.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Travelers Compan's Piotroski F-Score?

Travelers Compan (TRV) has a Piotroski F-Score of 5 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Travelers Compan's earnings high quality?

Travelers Compan (TRV) has an earnings quality ratio of 1.69x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Travelers Compan?

Travelers Compan (TRV) scores 46 out of 100 on our Financial Health Score, indicating moderate standing within its insurers peer group. The score is a 0-100 composite of six dimensions (Loss Ratio, Premium Growth, Capital, Investment Yield, Combined Ratio, Stability), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.